Olympios Papadimitriou holds the position of General Manager at Novo Nordisk Hellas LTD in the last 19 years.
He started his career in the pharmaceutical sector in 1990, working as a sales representative at Wyeth (later absorbed by Pfizer), based in Thessaloniki. In less than a year, he joined Schering AG Berlin (later absorbed by Bayer). After completing a three-year term at Schering AG, he joined Novo Nordisk Hellas as a medical representative in 1994. He served for 6 years in the field of medical sales, and then for 5 years in the marketing department of diabetes. He became General Manager of Novo Nordisk Hellas in December 2005
Olympios Papadimitriou became a member of the SFEE Board of Directors in 2013, and as of March 2018 he is the president of SFEE.
Olympios Papadimitriou is a graduate of the German School of Thessaloniki and he also holds a Diploma in Chemistry from Aristotelion University of Thessaloniki. He has attended Young Manager’s Program at INSEAD and he speaks fluently English and German.
Programming Partner: Hellenic Association of Pharmaceutical Companies (SFEE) & EFPIA (European Federation of Pharmaceutical Industries and Associations)
